new approach for safety evaluation of oligonucleotide therapeutics using rnaseq
Published 8 years ago • 200 plays • Length 24:01Download video MP4
Download video MP3
Similar videos
-
1:28:09
safety of therapeutic oligonucleotides
-
1:01:28
chemical and nanotechnology based approaches to build next gen oligonucleotide therapeutics
-
35:00
quantification methods for oligonucleotide therapeutics in serum and tissue
-
1:04:31
antisense oligonucleotide based therapies for inherited retinal diseases from mutation to clinical
-
23:35
antisense oligonucleotide therapy
-
6:54
developing next-generation oligonucleotide therapeutics
-
23:23
oligonucleotides as a new therapeutic class: progress report & prescription
-
9:25
what are oligonucleotide therapeutics, and how do they work?
-
54:11
shalini andersson: developing oligonucleotides into therapies
-
1:14:41
2023 ots paper of the year by jinkuk kim: a framework for indiv. splice-switching oligotherapy
-
50:32
annemieke aartsma-rus: design of exon skipping oligonucleotides
-
19:33
oligo meeting 2017 - rnai drug discovery
-
13:49
oligonucleotide therapeutics: new drugs that could stop covid-19
-
59:20
anastasia khvorova: rnai-based therapeutics: 2018 outlook
-
25:14
regulatory applications of a nonclinical database for oligonucleotide therapeutics at u.s. fda
-
1:42
oligonucleotide-based therapeutics
-
30:55
nonclinical strategies for oligonucleotide development programs
-
17:38
oligo meeting 2017 - target knock down - asos and sirna
-
43:14
introduction to regulatory science at the fda